Patents-Review.com
ClassID:

96532 ⎘

C07J31/00 - CPC Classification

Classification description:

Normal steroids, i.e. cyclopenta(a)hydrophenanthrenes, containing sulfur

Sub-classes:
Recent Application in this class:
#1
20260102373
2026-04-16

LYMPH DIRECTING PRODRUGS

 #2
20250352510
2025-11-20

LYMPH DIRECTING PRODRUGS

 #3
20250213522
2025-07-03

LYMPH DIRECTING PRODRUGS

 #4
20250042934
2025-02-06

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #5
20230365618
2023-11-16

CRYSTALLINE THIOCHOLESTEROL

 #6
20230357308
2023-11-09

CRYSTALLINE SODIUM CHOLESTERYL SULFONATE

 #7
20230279043
2023-09-07

Compositions and methods for treating CNS disorders

 #8
20210269473
2021-09-02

TGR5 MODULATORS AND METHODS OF USE THEREOF

 #9
20210017218
2021-01-21

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #10
20200024298
2020-01-23

PROCESS FOR THE PREPARATION OF FLUTICASONE PROPIONATE FORM I

 #11
20190105299
2019-04-11

LYMPH DIRECTING PRODRUGS

 #12
20180016295
2018-01-18

TGR5 Modulators and Methods of Use Thereof

 #13
20170342102
2017-11-30

Compositions and methods for treating CNS disorders

 #14
20170326103
2017-11-16

Lymph directing prodrugs

 #15
20160052956
2016-02-25

TGR5 modulators and methods of use thereof

 #16
20160009753
2016-01-14

Reducing risk of contracting clostridium-difficile associated disease

 #17
20140148593
2014-05-29

Process for preparing fluticasone propionate/furoate

 #18
20140141247
2014-05-22

Process for the preparation of fluticasone propionate form 1

 #19
20140100209
2014-04-10

TGR5 modulators and methods of use thereof

 #20
20140045808
2014-02-13

Reducing risk of contracting associated disease

 #21
20130274461
2013-10-17

Method for preparing fluticasone furoate

 #22
20120115832
2012-05-10

TGR5 modulators and methods of use thereof

 #23
20120071454
2012-03-22

Steroid compounds and treatment methods

 #24
20110172198
2011-07-14

TGR5 modulators and methods of use thereof

 #25
20110098260
2011-04-28

Steroid compounds and formulations

 #26
20100240633
2010-09-23

Cancer treatment methods

 #27
20100152151
2010-06-17

TGR5 modulators and methods of use thereof

 #28
20090118495
2009-05-07

Process for the preparation of 6-α,9-α-difluoro-17-α-((2-furanylcarbonyl)oxy)-11-β-hydroxy-16-α-methy1-3-oxo-androsta-1,4-diene-17-β- -carbothioic acid S-fluoromethyl

 #29
20080176823
2008-07-24

Breast and prostate cancer treatment method

 #30
20080125407
2008-05-29

METHOD FOR PREPARATION OF FLUTICASONE PROPIONATE

 #31
20080058301
2008-03-06

Formulations

 #32
20080021006
2008-01-24

Pharmaceutical compositions

 #33
20070298456
2007-12-27

Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof

 #34
20070292967
2007-12-20

Assay for Ligands of the Ecdysone Receptor

 #35
20070155781
2007-07-05

Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders

 #36
20060224004
2006-10-05

Process for preparing ursodeoxycholic acid di-sodium 3,7-disulfate

 #37
20060211670
2006-09-21

Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates

 #38
20060183727
2006-08-17

Estrogenic compounds as anti-mitotic agents

 #39
20060014727
2006-01-19

Angiogenic compounds and uses thereof

 #40
20050222098
2005-10-06

Regulation of meiosis

 #41
20050209477
2005-09-22

Process for producing vinyl perfluoroalkanesulfonate derivative

 #42
20050101583
2005-05-12

Process and intermediates for the production of 7-substituted antiestrogens

 #43
20050090675
2005-04-28

Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof

 #44
20050090477
2005-04-28

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof

 #45
20050043284
2005-02-24

Crystalline complexes of fluticasone-2-furoate